ACAD:Acadia Pharmaceuticals Inc - Stock Price Quote and Dividend Data
ACAD STOCK PRICE LATEST CLOSE
$14.10
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
Acadia Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
Acadia Pharmaceuticals Inc Stock Price Information
52-Week Low/High Stock Price$13.87 - $20.68
Percent Held by Institutions96.19%
Revenue$1,217,399,000
Net Income$370,193,000
Cash Flow$198,100,000
EPS0.87%
Market Cap$2,351,724,900
PE Ratio to Industry40%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.42%
Total Return Last 12 Months-20.79%
Total Return Last 3 Years-45.77%
Total Return Last 5 Years-67.06%
Latest Trade DateApr. 08, 2025
Acadia Pharmaceuticals Inc Annual Stock Dividends
No Data available for Payment History.
Acadia Pharmaceuticals Inc Dividend Payment History
| No dividends retrieved for ACAD |
Acadia Pharmaceuticals Inc Other Dividend Details
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. Co. is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Aug. 08, 2024ACAD STOCK PRICE DECREASE: Acadia Pharmaceuticals Inc on 08-08-2024 decreased stock price > 10% from $18.85 to $15.17
May. 10, 2024ACAD STOCK PRICE DECREASE: Acadia Pharmaceuticals Inc on 05-10-2024 decreased stock price > 10% from $17.13 to $15.21
Mar. 13, 2024ACAD STOCK PRICE DECREASE: Acadia Pharmaceuticals Inc on 03-13-2024 decreased stock price > 10% from $24.13 to $19.98
Dec. 14, 2023ACAD STOCK PRICE INCREASE: Acadia Pharmaceuticals Inc on 12-14-2023 increased stock price > 10% from $21.17 to $28.47
Sep. 29, 2023ACAD STOCK PRICE DECREASE: Acadia Pharmaceuticals Inc on 09-29-2023 decreased stock price > 10% from $25.58 to $21.53
Jul. 15, 2023ACAD STOCK PRICE INCREASE: Acadia Pharmaceuticals Inc on 07-15-2023 increased stock price > 10% from $25.80 to $32.18
Oct. 08, 2022ACAD STOCK PRICE DECREASE: Acadia Pharmaceuticals Inc on 10-08-2022 decreased stock price > 10% from $18.63 to $16.29
Jun. 22, 2022ACAD STOCK PRICE DECREASE: Acadia Pharmaceuticals Inc on 06-22-2022 decreased stock price > 10% from $19.51 to $13.01
Jun. 16, 2022ACAD STOCK PRICE INCREASE: Acadia Pharmaceuticals Inc on 06-16-2022 increased stock price > 10% from $16.25 to $18.77
Jun. 04, 2022ACAD STOCK PRICE INCREASE: Acadia Pharmaceuticals Inc on 06-04-2022 increased stock price > 10% from $16.21 to $17.90
Apr. 09, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-09-2025 decreased stock price > 10% from $16.45 to $14.21
Apr. 09, 2025RNTX STOCK PRICE DECREASE: Rein Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $1.64 to $1.39
Apr. 09, 2025IRD STOCK PRICE DECREASE: Opus Genetics Inc on 04-09-2025 decreased stock price > 10% from $0.85 to $0.75
Apr. 09, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-09-2025 decreased stock price > 10% from $4.05 to $3.61
Apr. 09, 2025CLYM STOCK PRICE DECREASE: Climb Bio Inc on 04-09-2025 decreased stock price > 10% from $1.26 to $1.13
Apr. 09, 2025KAPA STOCK PRICE DECREASE: Kairos Pharma Ltd on 04-09-2025 decreased stock price > 10% from $1.14 to $0.97
Apr. 09, 2025IBO STOCK PRICE DECREASE: Impact Biomedical Inc on 04-09-2025 decreased stock price > 10% from $0.87 to $0.65
Apr. 09, 2025ZBIO STOCK PRICE DECREASE: Zenas BioPharma Inc on 04-09-2025 decreased stock price > 10% from $7.75 to $6.77
Apr. 09, 2025EVOK STOCK PRICE DECREASE: Com Par $0.0001/Evoke Pharma Inc on 04-09-2025 decreased stock price > 10% from $2.35 to $2.07
Apr. 09, 2025TNFA STOCK PRICE DECREASE: TNF Pharmaceuticals Inc on 04-09-2025 decreased stock price > 10% from $0.37 to $0.26
